Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. (Q39207993)
Jump to navigation
Jump to search
scientific article published on 16 January 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. |
scientific article published on 16 January 2013 |
Statements
Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK (English)
Chi-Hsiang Chiang
Wen-Chun Hung
16 January 2013